Markus Neuber studied biotechnology at the Beuth University of Applied Sciences Berlin and at the Saarland University in Saarbrücken. In October 2017, he graduated from Saarland University with a Master's thesis on "Optimization of griselimycins and mycoplanecins production through metabolic and bioprocess engineering".
Since 2018, he is a PhD student in the HIPS-department Microbial Natural Products led by Prof. Dr. Rolf Müller. His PhD project aims at the development of co-cultivation strategies for myxobacteria to access new secondary metabolites. Co-cultivation of microorganisms has been successful in isolating unknown secondary metabolites, including antibiotics, thus opening up new avenues for the production of bioactive compounds.